QuantLogix ← CME scorecard
📅 CME Earnings Preview
CME
Next report (est.)
01/22/2027
Countdown
87 days
EPS growth YoY
+16.1%
Revenue growth YoY
+13.0%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
10/23/2026 ±2.2% -0.1% over-priced
07/24/2026 ±3.5% +0.4% over-priced
04/24/2026 ±2.8% -0.1% over-priced
02/26/2026 ±2.4% +3.0% under-priced
10/24/2025 ±2.1% +0.2% over-priced
07/25/2025 ±1.8% +0.9% over-priced
04/30/2025 ±2.6% +1.7% over-priced
02/27/2025 ±1.4% +0.8% over-priced
Across these reports, options implied an average ±2.4% move vs an actual average of 0.9% — the stock stayed inside the implied band 88% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q3 FY2026 $2.89 $1.7B $1.0B
Q2 FY2026 $2.88 $1.7B $1.0B
Q1 FY2026 $3.18 $1.9B $1.2B
Q4 FY2025 — $1.6B $1.2B
Analyst posture
Buy / Strong Buy
11
Hold
7
Sell
3
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 84/100 Full scorecard →
Get alerted before every CME report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CME before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

CME (CME) reports in 87 days, with the next report estimated for 01/22/2027. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced CME's earnings risk. Fundamentals into the print: EPS up 16.1% year-over-year, revenue up 13.0%. QuantLogix's live 5-factor engine currently reads CME as a buy at 84/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →